TR-1: Notification of Major Interest in Shares

27th Sep 2010 11:40

For filings with the FSA include the annex For filings with issuer exclude the annex

TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARESi

1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are Sinclair Pharma

Plcattached:ii

2 Reason for the notification (please tick the appropriate box or boxes): An acquisition or disposal of voting rights

Yes

An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights No are attached

An acquisition or disposal of instruments with similar economic effect to No qualifying financial instruments

An event changing the breakdown of voting rights

No Other (please specify): No 3. Full name of person(s) subject to the Gartmore Investment Limited notification obligation:iii

4. Full name of shareholder(s) See attached schedule

(if different from 3.):iv

5. Date of the transaction and date on which the threshold is crossed or 21st September 2010

reached: v

6. Date on which issuer notified: 22nd September 2010 7. Threshold(s) that is/are crossed: vi, vii 5%

8. Notified details:

A: Voting rights attached to shares viii, ix Class/type Situation previous Resulting situation after the triggering transaction of to the triggering shares transaction if possible Number Number Number Number of voting % of voting rights using of of of shares rights x the ISIN Shares Voting CODE Rights Direct Direct

xi Indirect xii Direct Indirect

GB0033856740 9,214,218 9,214,218 7,747,766 7,747,766 4.765%

B: Qualifying Financial Instruments Resulting situation after the triggering transaction Type of financial Expiration Exercise/ Number of voting % of voting instrument date xiii Conversion Period xiv rights that may be rights acquired if the instrument is exercised/ converted. C: Financial Instruments with similar economic effect to Qualifying Financial Instruments xv, xvi

Resulting situation after the triggering transaction Type of Exercise price Expiration date Exercise/ Number of voting rights % of voting financial xvii Conversion period instrument refers to rights xix, xx instrument xviii Nominal Delta Total (A+B+C) Number of voting rights Percentage of voting rights 7,747,766 4.765%

9. Chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held, if applicable: xxi

Proxy Voting: 10. Name of the proxy holder:

11. Number of voting rights proxy holder will cease

to hold:

12. Date on which proxy holder will cease to hold

voting rights: All figures are based on the Company's issued 13. Additional information: share capital of 162,601,357 as provided by Exshare E mail contact [email protected] 14. Contact name: RDU

15. Contact telephone number: 0207 782 2224

vendor

---

Related Shares:

Sinclair Pharma